D. Dutoit et al., RED-BLOOD-CELLS HALOPERIDOL REDUCTASE-ACT IVITY - INTEREST IN THE INITIATION OF HALOPERIDOL TREATMENT, Therapie, 49(1), 1994, pp. 71-74
Serum levels of haloperidol and reduced haloperidol as well as the red
uced haloperidol/haloperidol ratios were determined in nine acute schi
zophrenics on oral haloperidol medication and correlated over 21 days
with psyche pathology and extra-pyramidal symptom scores. We have inve
stigated red blood cells haloperidol reductase activity in the group o
f patients. Significant correlations were found between haloperidol pl
asma levels and positive sub scale for each patient (r = 0,86 and p <
0,01; r = 0,70 and p c 0,05). We found a correlation between red blood
cells reductase activity and the improvement of the psychotic anxiety
scale (r = 0,64/and p < 0,05; r = 0,67 and p < 0,05), but not with re
duced haloperidol/haloperidol ratios in plasma. The knowledge of reduc
tase activity could predict the treatment response in acute schizophre
nic patients. We suggest that the reported inter individual and inter
ethnic differences in haloperidol and reduced haloperidol and in clini
cal response and adverse effects may be a reflection of genetic contro
l of the two oxidative pathways mediated by cytochrome P450 isozyme an
d/or the reductase pathway mediated by haloperidol reductase in indivi
dual subject.